Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-21

Clinical Trial Update: Altis® 522 Trial - Treatment of Female Stress Urinary Incontinence

View source ↗

Summary

Clinical trial update for Altis 522 evaluating treatment of stress urinary incontinence has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Altis 522

Snippet

Sponsor: Coloplast A/S | Conditions: Stress Urinary Incontinence | Status: COMPLETED | Results posted: 2023-11-21